Minimizing risk associated with elderly liver donors by matching to preferred recipients

Hepatology

Volumn 46, Issue 6, 2007, Pages 1907-1918

  Segev, Dorry L ^a,b   Maley, Warren R ^a   Simpkins, Christopher E ^a   Locke, Jayme E ^a   Nguyen, Geoffrey C ^a   Montgomery, Robert A ^a   Thuluvath, Paul J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; COLD ISCHEMIA; COMPARATIVE STUDY; FEMALE; GERIATRICS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; TISSUE DONORS; UNITED STATES;

EID: 37749046119     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21888     Document Type: Article

References (32)

1. United Network for Organ Sharing. Organ Procurement and Transplantation Network data. Available at: www.unos.org. Accessed September 18, 2006.
2. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-663.
3. Amin MG, Wolf MP, TenBrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004;10:1468-1475.
4. United Network for Organ Sharing. Organ Procurement and Transplantation Network data as of June 6, 2006, obtained from and through the United Network for Organ Sharing STAR files. Available at: www.unos.org. Accessed June 6, 2006.
5. Escartin A, Castro E, Dopazo C, Bueno J, Bilbao I, Margarit C. Analysis of discarded livers for transplantation. Transplant Proc 2005;37:3859-3860.
6. Sayuk GS, Leet TL, Schnitzler MA, Hayashi PH. Nontransplantation of livers from deceased donors who are able to donate another solid organ: how often and why it happens. Am J Transplant 2007;7:151-160.
7. Busquets J, Xiol X, Figueras J, Jaurrieta E, Torras J, Ramos E, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001;71:1765-1771.
8. Rull R, Vidal O, Momblan D, Gonzalez FX, Lopez-Boado MA, Fuster J, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 2003;9:389-393.
9. Quintieri F, Pugliese O, Mattucci DA, Taioli E, Venettoni S, Costa AN. Liver transplantation in Italy: analysis of risk factors associated with graft outcome. Prog Transplant 2006;16:57-64.
10. Grazi GL, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, et al. Using elderly donors in liver transplantation. Transplant Proc 2005;37:2582-2583.
11. Moore DE, Feurer ID, Speroff T, Gorden DL, Wright JK, Chari RS, et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005;140:273-277.
12. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, Deb-Roy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
13. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001;33:464-470.
14. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
15. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004;4:819-825.
16. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996;62:62-65.
17. Cescon M, Grazi GL, Ercolani G, Nardo B, Ravaioli M, Gardini A, et al. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl 2003;9:1174-1180.
18. Jimenez Romero C, Moreno Gonzalez E, Colina Ruiz F, Palma Carazo F, Loinaz Segurola C, Rodriguez Gonzalez F, et al. Use of octogenarian livers safely expands the donor pool. Transplantation 1999;68:572-575.
19. Zapletal C, Faust D, Wullstein C, Woeste G, Caspary WF, Golling M, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 2005;37:1182-1185.
20. Gastaca M, Valdivieso A, Pijoan J, Errazti G, Hernandez M, Gonzalez J, et al. Donors older than 70 years in liver transplantation. Transplant Proc 2005;37:3851-3854.
21. Borchert D, Glanemann M, Mogl M, Langrehr JM, Neuhaus P. Older liver graft transplantation, cholestasis and synthetic graft function. Transpl Int 2005;18:709-715.
22. Borchert DH, Glanemann M, Mogl M, Langrehr J, Neuhaus P. Adult liver transplantation using liver grafts from donors over 70 years of age. Transplant Proc 2005;37:1186-1187.
23. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, et al. Histological recurrent hepatitis C after liver transplantation: outcome and role of retransplantation. Liver Transpl 2006;12:1104-1111.
24. Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006;81:7-14.
25. Kim DY, Cauduro SP, Bohorquez HE, Ishitani MB, Nyberg SL, Rosen CB. Routine use of livers from deceased donors older than 70: is it justified? Transpl Int 2005;18:73-77.
26. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005;5:549-557.
27. Northup PG, Pruett TL, Stukenborg GJ, Berg CL. Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant 2006;6:2455-2462.
28. Salizzoni M, Franchello A, Zamboni F, Ricchiuti A, Cocchis D, Fop F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003;16:486-493.
29. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-505.
30. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.
31. Nardo B, Masetti M, Urbani L, Caraceni P, Montalti R, Filipponi F, et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 2004;4:1139-1147.
32. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995;60:790-794.